India’s ambitious Rs 70,000 crore maritime push, including infrastructure status for large ships, aims to revolutionize shipbuilding. This initiative targets a significant increase in global market share, potentially generating 30 lakh jobs and attracting substantial investment.Read More

Citi has re-initiated coverage on State Bank of India (SBI) with a ‘Buy’ rating and a target price of Rs 1,050, citing strong credit growth, improved returns, and operational efficiencies. The brokerage expects FY26–FY27 loan growth of 13–14%, NIMs of 2.8–2.9%, and ROE of 14–15%. Risks include asset slippages, lower NIMs, and higher credit costs.Read More

Gains in consumption-focused stocks, buoyed by expectations of a festive-season boost, helped offset caution stemming from persistent foreign outflows and fresh U.S. visa restrictions.Read More

Navratri sales boost the auto sector. Auto component makers are growing faster than car companies. Shares of Banco Products and JTEKT India rise sharply. The auto components market is expected to reach $200 billion by 2030. Premiumization and EV transition are driving growth. Government policies support domestic manufacturing. Experts suggest auto ancillaries offer better investment...Read More

Glenmark Pharma shares: The company’s unit Glenmark Specialty S.A. signed an exclusive licensing deal with China’s Hengrui Pharma for Trastuzumab Rezetecan, a next-gen HER2-targeting ADC. The pact includes an upfront payment of $18 million, milestone payouts of up to $1.093 billion, and royalties on sales.Read More

The Union Cabinet cleared a ₹69,725 crore revival package for the shipbuilding industry. The plan, built on a four-pillar approach, aims to boost domestic capacity, ease financing, support shipyard development, enhance technical skills, and roll out legal, tax, and policy reforms to strengthen India’s maritime ecosystem.Read More

Lupin’s shares surged by 2.2% following tentative U.S. FDA approval for its generic HIV treatment, Bictegravir, Emtricitabine, and Tenofovir Alafenamide Tablets. This positions Lupin to enter a significant U.S. market segment with estimated annual sales of $16.237 billion. The drug, a generic version of Gilead Sciences’ Biktarvy, will be manufactured at Lupin’s Nagpur facility.Read More

Tata Motors share price: Tata Motors’ UK subsidiary Jaguar Land Rover (JLR) may face a £2 billion loss from an ongoing cyberattack that halted production at key facilities. With no cyber insurance in place, the disruption could exceed last year’s profit, impacting around 33,000 employees and JLR’s contribution to Tata Motors’ revenue.Read More

A 5-year swing high refers to the highest price a stock has reached within a five-year period.Read More

As of September 24, there was a notable surge in futures open interest (OI) for six stocks in the NSE F&O pack, contributing to a total increase of over 8% compared with the previous session.Read More